High Court seeks reason for rejection of prostrate cancer drug patent
The Delhi High Court has asked the Centre to explain on what basis the Indian patent office has rejected the application by the Regents of University of California seeking a patent for its prostrate cancer drug.
Mar 05, 2017, 15:52 PM IST